NUTRITIONAL COMPOSITIONS
    1.
    发明申请
    NUTRITIONAL COMPOSITIONS 审中-公开
    营养成分

    公开(公告)号:US20100184150A1

    公开(公告)日:2010-07-22

    申请号:US12664192

    申请日:2008-06-13

    IPC分类号: C12P19/00

    摘要: The present invention is directed to a novel saccharide composition isolated from a yeast culture. The invention is also directed to yeast cell based saccharide composition with increased water-solubility. The saccharide compositions disclosed in the invention can be used as nutritional or pharmaceutical additives or as part of nutritional or pharmaceutical composition in order to promote the health of an animal or human subject to which said composition is administered. The invention is also directed to methods of producing said saccharide compositions.

    摘要翻译: 本发明涉及从酵母培养物中分离的新型糖组合物。 本发明还涉及具有增加的水溶性的酵母细胞基糖组合物。 本发明公开的糖组合物可以用作营养或药物添加剂或作为营养或药物组合物的一部分,以便促进给予所述组合物的动物或人受试者的健康。 本发明还涉及生产所述糖组合物的方法。

    Compounds and Combinations
    4.
    发明申请
    Compounds and Combinations 失效
    化合物和组合

    公开(公告)号:US20110274646A1

    公开(公告)日:2011-11-10

    申请号:US13102451

    申请日:2011-05-06

    摘要: The present invention relates to a combination of a hyaluronan oligomer and/or polymer and a factor capable of mobilizing stem cells. The present invention also relates to a method for altering the relative amounts of blood cells and/or the types of blood cells in a subject by administering the combination to the subject. Further, the present invention relates to a method for mobilizing stem cells to the bloodstream of a subject by administering the combination to the subject. Additionally, the present invention relates to a hyaluronan oligomer and/or polymer.

    摘要翻译: 本发明涉及透明质酸低聚物和/或聚合物的组合以及能够动员干细胞的因子。 本发明还涉及通过对受试者施用组合来改变受试者的血细胞相对量和/或血细胞类型的方法。 此外,本发明涉及一种通过向受试者施用组合来将干细胞移动到受试者的血液中的方法。 另外,本发明涉及透明质酸低聚物和/或聚合物。

    Cancer specific oligosaccharide sequences and use thereof
    5.
    发明授权
    Cancer specific oligosaccharide sequences and use thereof 有权
    癌细胞特异性寡糖序列及其用途

    公开(公告)号:US08313912B2

    公开(公告)日:2012-11-20

    申请号:US10486714

    申请日:2002-08-16

    IPC分类号: G01N33/53 G01N33/574

    摘要: The invention concerns a method for diagnosing cancer in a biological sample by determining the presence of a LacdiNAc oligosaccharide sequence. The invention can be used for diagnostic agents, pharmaceutical compositions, cancer vaccines, and antigenic carbohydrate substances. The presence of cancer and malignancies is determined by contacting the biological sample with a reagent that binds to the oligosaccharide sequence. This same method can also be used in the treatment of cancer and malignancies.

    摘要翻译: 本发明涉及通过确定LacdiNAc寡糖序列的存在来诊断生物样品中的癌症的方法。 本发明可用于诊断剂,药物组合物,癌症疫苗和抗原性碳水化合物物质。 通过使生物样品与结合寡糖序列的试剂接触来确定癌症和恶性肿瘤的存在。 同样的方法也可用于治疗癌症和恶性肿瘤。

    Compounds and combinations
    7.
    发明授权
    Compounds and combinations 失效
    化合物和组合

    公开(公告)号:US08546353B2

    公开(公告)日:2013-10-01

    申请号:US13102451

    申请日:2011-05-06

    摘要: The present invention relates to a combination of a hyaluronan oligomer and/or polymer and a factor capable of mobilizing stem cells. The present invention also relates to a method for altering the relative amounts of blood cells and/or the types of blood cells in a subject by administering the combination to the subject. Further, the present invention relates to a method for mobilizing stem cells to the bloodstream of a subject by administering the combination to the subject. Additionally, the present invention relates to a hyaluronan oligomer and/or polymer.

    摘要翻译: 本发明涉及透明质酸低聚物和/或聚合物的组合以及能够动员干细胞的因子。 本发明还涉及通过对受试者施用组合来改变受试者的血细胞相对量和/或血细胞类型的方法。 此外,本发明涉及一种通过向受试者施用组合来将干细胞移动到受试者的血液中的方法。 另外,本发明涉及透明质酸低聚物和/或聚合物。